DOACs: Difference between revisions
Category page
More actions
Create canonical category-page article (history-first) |
Rewrite per canonical category-page spec (history-first article) |
||
| Line 14: | Line 14: | ||
* '''Direct thrombin inhibitor (factor IIa)''': | * '''Direct thrombin inhibitor (factor IIa)''': | ||
** [[wikipedia:Dabigatran|Dabigatran etexilate]] (Pradaxa; | ** [[wikipedia:Dabigatran|Dabigatran etexilate]] (Pradaxa; the orally bioavailable form, hydrolysed by serum esterases to the active dabigatran; the first DOAC) | ||
* '''[[:Category:Direct_factor_Xa_inhibitors|Direct factor Xa inhibitors]]''': | * '''[[:Category:Direct_factor_Xa_inhibitors|Direct factor Xa inhibitors]]''': | ||
** [[Rivaroxaban|Rivaroxaban]] (Xarelto, Bayer/Janssen) | ** [[Rivaroxaban|Rivaroxaban]] (Xarelto, Bayer/Janssen) | ||